Experts at India's drug regulator were meeting on Wednesday to consider approving an AstraZeneca/Oxford coronavirus vaccine for emergency use after Britain became the first country to do so, two sources with knowledge of the matter said. A representative of India's Central Drugs Standard Control Organization (CDSCO) declined to reveal the agenda of the meeting but said its minutes would be uploaded on its website within hours. Sources earlier told Reuters the CDSCO was likely to approve the vaccine this week after its local manufacturer, Serum Institute of India (SII), ...
India drug regulator meets to discuss AstraZeneca vaccine: Report
SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses, enough for 25 million people